z-logo
open-access-imgOpen Access
Health care costs and utilization of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents
Author(s) -
Nicole Meyer,
Yanni Hao,
Pamela LandsmanBlumberg,
William Johnson,
Paul Juneau,
Jaqueline Willemann Rogerio
Publication year - 2015
Publication title -
comparative effectiveness research
Language(s) - English
Resource type - Journals
ISSN - 1179-8483
DOI - 10.2147/cer.s62090
Subject(s) - medicine , breast cancer , receipt , metastatic breast cancer , health care , population , cancer , trastuzumab , oncology , family medicine , environmental health , economics , economic growth , world wide web , computer science

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom